These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9834752)

  • 1. United Kingdom prospective diabetes study results are in.
    Genuth S
    J Fam Pract; 1998 Nov; 47(5 Suppl):S27. PubMed ID: 9834752
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care.
    Srimanunthiphol J; Beddow R; Arakaki R
    Hawaii Med J; 2000 Jul; 59(7):295-8, 313. PubMed ID: 10961040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prospective pioglitazone clinical trial in macrovascular events].
    Asanuma H; Kitakaze M
    Nihon Rinsho; 2012 May; 70 Suppl 3():301-8. PubMed ID: 22768537
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes.
    Genuth S
    Obes Res; 2000 Mar; 8(2):198-201. PubMed ID: 10757207
    [No Abstract]   [Full Text] [Related]  

  • 5. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 6. [The UKPDS after one year. Diabetological realities and desiderata. United Kingdom Prospective Diabetes Study].
    Mehnert H
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1021. PubMed ID: 10506838
    [No Abstract]   [Full Text] [Related]  

  • 7. The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
    Matthews DR
    Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S7-13. PubMed ID: 11221801
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical advances in diabetes].
    Martin S; Scherbaum WA
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
    [No Abstract]   [Full Text] [Related]  

  • 11. [United Kingdom Prospective Diabetes Study: facts and questions].
    Spinas GA
    Schweiz Med Wochenschr; 1998 Dec; 128(51-52):2043-6. PubMed ID: 10025005
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of the United Kingdom Prospective Diabetes Study and its results].
    Pospísilová Y
    Vnitr Lek; 2000 Oct; 46(10):709-14. PubMed ID: 11344631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular safety of antidiabetics].
    Aline Roth PW; Jornayvaz FR
    Rev Med Suisse; 2016 Jun; 12(521):1084, 1086-8. PubMed ID: 27487675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
    Goodarzi MO; Psaty BM
    JAMA; 2008 Nov; 300(17):2051-3. PubMed ID: 18984894
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 18. [Type 2 diabetes: is the treatment based on evidence?].
    Boussageon R
    Rev Med Suisse; 2010 Sep; 6(260):1624-5; author reply 1625. PubMed ID: 20853719
    [No Abstract]   [Full Text] [Related]  

  • 19. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How does the PROactive Study change therapy of diabetes?].
    Erdmann E
    MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.